Xinhua News Agency, New Delhi, May 26 (Reporter Zhao Xu) The Minister of Chemical Industry and Fertilizer of India said on the 26th that up to now, more than 10,000 cases of mucormycosis have been reported across India, reaching 11,717.
Gundam posted information about mucormycosis in India on social media that day.
He said that currently 11,717 cases of mucormycosis have been reported across India. Gujarat, the state with the most cases, has reported 2,859 cases, Maharashtra has reported 2,770 cases, and Andhra Pradesh, Madhya Pradesh and Telangana have reported more than 700 cases respectively.
Gao said that the Indian government distributed 29,250 bottles of amphotericin B, a drug used to treat mucormycosis, to various states on the same day to help localities cope with the spread of mucormycosis.
On the 20th, the Indian Ministry of Health required states to declare mucormycosis as a notifiable statutory epidemic in accordance with the Epidemiology Act, and called on all medical institutions to screen, diagnose and treat mucormycosis in accordance with government procedures.
Rajasthan, Gujarat, Haryana and other places have successively declared mucormycosis as a legal epidemic.
As of the 21st, at least 7,250 cases of mucormycosis in patients with new crowns have been reported across India, and at least 219 people have died.
Indian health experts call mucormycosis an "epidemic disease", caused by the "mucor mold" fungus that exists in the natural environment. New crown patients with diabetes are susceptible to infection with the bacteria after hormone therapy, and their symptoms are headaches. , Nose bleeding, hemoptysis, facial numbness and swelling, blurred vision, difficulty breathing, etc., have a high fatality rate.